Abstract | BACKGROUND: METHODS: RESULTS: In eight of 10 patients, an elevated serum tryptase level was found. In two of 10 patients, no venom-specific IgE could be detected by either skin tests or RAST. Five patients had no detectable venom-specific serum IgE, and in the remaining patients the level was low (<1 Phadebas RAST unit). Venom immunotherapy was well tolerated and caused only one mild systemic reaction in a patient during the dose increase phase. Six patients were re-stung while receiving venom immunotherapy: only one had a mild systemic reaction ( angioedema) after a Vespula sting. CONCLUSION:
|
Authors | M Fricker, A Helbling, L Schwartz, U Müller |
Journal | The Journal of allergy and clinical immunology
(J Allergy Clin Immunol)
Vol. 100
Issue 1
Pg. 11-5
(Jul 1997)
ISSN: 0091-6749 [Print] United States |
PMID | 9257781
(Publication Type: Journal Article)
|
Chemical References |
- Bee Venoms
- Wasp Venoms
- Immunoglobulin E
|
Topics |
- Adult
- Anaphylaxis
(immunology, therapy)
- Animals
- Bee Venoms
(immunology, therapeutic use)
- Desensitization, Immunologic
- Female
- Humans
- Hymenoptera
(immunology)
- Immunoglobulin E
(blood)
- Insect Bites and Stings
(immunology, therapy)
- Male
- Middle Aged
- Urticaria Pigmentosa
(immunology, therapy)
- Wasp Venoms
(immunology, therapeutic use)
|